US FDA lifts hold on Bharat Biotech’s COVID-19 vaccine Covaxin’s clinical trials in America
Image Credit: PTI
The US Food and Drug Administration which has put on hold the phase 2/ 3 clinical trials of Bharat Biotech's COVID-19 vaccine Covaxin, in USA, has lifted the pause, according to a statement issued by Ocugen Inc, Bharat Biotech's partner for the jab in USA and Canada. The FDA's earlier decision, in April, to put on hold the trials was based on the US firm's decision to voluntarily implement a temporary pause in dosing participants of the jab.